Olaparib Impurity 113 | CAS 2243897-05-2 - Request Quote
Olaparib Impurity 113
| SZ CAT No: | SZ-O033124 |
| CAS No | 2243897-05-2 |
| Mol.F. | C24H23FN4O3 |
| Mol.Wt. | 434.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olaparib Impurity 113 is chemically (E)-4-(3-(4-(but-2-enoyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one. Olaparib Impurity 113 is supplied with detailed characterization data compliant with regulatory guideline. Olaparib Impurity 113 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olaparib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2243897-05-2
Purchase 2243897-05-2
Order 2243897-05-2
Enquire 2243897-05-2
price of 2243897-05-2
2243897-05-2 Supplier
2243897-05-2 Manufacturer
2243897-05-2 Exporter
buy high quality Olaparib Impurity 113
Purchase Olaparib Impurity 113
Olaparib Impurity 113 suppliers
Olaparib Impurity 113 manufacturers
Olaparib Impurity 113 price
Order Olaparib Impurity 113
Enquire Olaparib Impurity 113
Olaparib Impurity 113 cost
Olaparib Impurity 113 Supplier
Olaparib Impurity 113 Distributor
Olaparib Impurity 113 for Method Validation
Olaparib Reference Standard
Olaparib Impurity 113 for ANDA Filing
Olaparib Impurity 113 for Forced Degradation Studies
Olaparib Impurity 113 Identification Standards
Olaparib Impurity 113 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


